Polymorphism of transcription factor-7-like 2 (TCF7L2) gene and new-onset diabetes after liver transplantation

International Journal of Organ Transplantation Medicine

Volumn 6, Issue 1, 2015, Pages 14-22

  Musavi, Z ^a,b   Azarpira, N ^a   Sangtarash, M H ^a,b   Kordi, M ^b   Kazemi, K ^a   Geramizadeh, B ^a   Malek Hosseini, S A ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b University of Medical Sciences   (Iran)

Author keywords

Diabetes mellitus; Genetic; Liver transplantation; Polymorphism; Transcription factor 7 like 2 protein; Transcription factors

Indexed keywords

GLUCOSE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; STEROID; TACROLIMUS; TRANSCRIPTION FACTOR 7 LIKE 2;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE PREDISPOSITION; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG PULSE THERAPY; FEMALE; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; GRAFT RECIPIENT; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEW ONSET DIABETES AFTER TRANSPLANTATION; ORGAN DONOR; PATIENT CODING; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84921796461     PISSN: 20086482     EISSN: 20086490     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Davidson J, Wilkinson A, Dantal J, et al. New-onset diabetes after transplantation. Transplantation 2003;75:10 Suppl:SS3-24.
2. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003;3:178-85.
3. Hooff JP, Christiaans MH, Duijnhoven EM. Tacrolimus and posttransplant diabetes mellitus in renal transplantation. Transplantation 2005;79:1465-9.
4. Bodziak KA, Hricik DE. New-onset diabetes mellitus after solid organ transplantation. Transpl Int 2009;22:519-30.
5. Voight BF, Scott LJ, Steinthorsdottir V, et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 2010;42:579-89.
6. Baid S, Cosimi AB, Farrell ML, et al. Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality. Transplantation 2001;72:1066-72.
7. Gane EJ. Diabetes mellitus following liver transplantation in patients with hepatitis C virus: risks and consequences. Am J Transplant 2012;12:531-8.
8. Sladek R, Rocheleau G, Rung J, et al. A genomewide association study identifies novel risk loci for type 2 diabetes. Nature 2007;445:881-5.
9. Uma Jyothi K, Jayaraj M, Subburaj KS, et al. Association of TCF7L2 Gene Polymorphisms with T2DM in the Population of Hyderabad, India. PLoS One 2013;8:e60212.
10. Grant SF, Thorleifsson G, Reynisdottir I, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006;38:320-23.
11. Cauchi S, El Achhab Y, Choquet H, et al. TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. J Molecul Med 2007;85:777-82.
12. Florez JC. The new type 2 diabetes gene TCF7L2. Curr Opin Clin Nutr Metab Care 2007;10:391-6.
13. da Silva Xavier G, Loder MK, McDonald A, et al. TCF7L2 regulates late events in insulin secretion from pancreatic islet beta-cells. Diabetes 2009;58:894-905.
14. Loder MK, da Silva Xavier G, McDonald A, Rutter GA. TCF7L2 controls insulin gene expression and insulin secretion in mature pancreatic beta-cells. Biochem Soc Trans 2008;36:357-9.
15. Rulifson IC, Karnik SK, Heiser PW, et al. Wnt signaling regulates pancreatic beta cell proliferation. Proc Natl Acad Sci USA 2007;104:6247-52.
16. Davidson JA, Wilkinson A. New-onset diabetes after transplantation 2003 international consensus guidelines: an endocrinologist's view. Diabetes Care 2004;27:805-12.
17. Schäfer SA, Tschritter O, Machicao F, et al. Impaired glucagonlike peptide-1 (GLP-1)-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms. Diabetologia 2007;50:2443-50.
18. Musso G, Gambino R, Pacini G, et al. Transcription factor 7-like 2 polymorphism modulates glucose and lipid homeostasis, adipokine profile, and hepatocyte apoptosis in NASH. Hepatology 2009;49:426-35.
19. Chakkera HA, Hanson RL, Raza SM, et al. Pilot study: association of traditional and genetic risk factors and new-onset diabetes mellitus following kidney transplantation. Transplant Proc 2009;41:4172-7.
20. Kurzawski M, Dziewanowski K, Łapczuk J, et al. Analysis of common type 2 diabetes mellitus genetic risk factors in new-onset diabetes after transplantation in kidney transplant patients medicated with tacrolimus. Eur J Clin Pharmacol 2012;68:1587-94.
21. Ghisdal L, Baron C, Le Meur Y, et al. TCF7L2 polymorphism associates with new-onset diabetes after transplantation. J Am Soc Nephrol 2009;20:2459-67.
22. Damcott CM, Pollin TI, Reinhart LJ, et al. Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance. Diabetes 2006;55:2654-9.
23. Ling Q, Xie H, Lu D, et al. Association between donor and recipient TCF7L2 gene polymorphisms and the risk of new-onset diabetes mellitus after liver transplantation in a Han Chinese population. J Hepatol 2013;58:271-7.
24. Parvizi Z, Azarpira N, Kohan L, ET AL. Association between E23K variant in KCNJ11 gene and newonset diabetes after liver transplantation. Mol Biol Rep 2014;41:6063-9.
25. Amoli MM, Amiri P, Tavakkoly-Bazzaz J, et al. Replication of TCF7L2 rs7903146 association with type 2 diabetes in an Iranian population. Genet Mol Biol 2010;33:449-51.
26. Barra GB, Dutra LA, Watanabe SC, et al. Association of the rs7903146 single nucleotide polymorphism at the Transcription Factor 7-like 2 (TCF7L2) locus with type 2 diabetes in Brazilian subjects. Arq Bras Endocrinol Metabol 2012;56:479-84.
27. Helgason A, Pálsson S, Thorleifsson G, et al. Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nat Genet 2007;39:218-25.
28. Long J, Edwards T, Signorello LB, et al. Evaluation of genome-wide association study-identified type 2 diabetes loci in African Americans. Am J Epidemiol 2012;176:995-1001.
29. Ségurel L, Austerlitz F, Toupance B, et al. Positive selection of protective variants for type 2 diabetes from the Neolithic onward: a case study in Central Asia. Ear J Hum Genet 2013;21:1146-51.
30. Maeda S, Osawa N, Hayashi T, et al. Genetic variations associated with diabetic nephropathy and type II diabetes in a Japanese population. Nat Genet 2007;39:218-25.
31. Ye X, Kuo H-T, Sampaio MS, et al. Risk factors for the development of new-onset diabetes mellitus after transplant in adult lung transplant recipients. Clin Transplant 2011;25:885-91.
32. Garro R, Warshaw B, Felner E. New-onset diabetes after kidney transplant in children. Pediatr Nephrol. 2014 Jun 4. [Epub ahead of print]